Cargando…

Embolia cutis Medicamentosa (Nicolau syndrome): case series

INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fekete, Gyula Laszlo, Iantovics, Laszlo Barna, Fekete, Júlia Edit, Fekete, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653301/
https://www.ncbi.nlm.nih.gov/pubmed/38020151
http://dx.doi.org/10.3389/fmed.2023.1216781
_version_ 1785136382466850816
author Fekete, Gyula Laszlo
Iantovics, Laszlo Barna
Fekete, Júlia Edit
Fekete, Laszlo
author_facet Fekete, Gyula Laszlo
Iantovics, Laszlo Barna
Fekete, Júlia Edit
Fekete, Laszlo
author_sort Fekete, Gyula Laszlo
collection PubMed
description INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was to describe and analyze the clinical characteristics of Nicolau syndrome in patients examined in daily dermatological practice. METHODS: We performed a retrospective chart review, between January 2011 and December 2020, in patients diagnosed with Nicolau syndrome, from the cases of a private dermatology medical office in Târgu Mureș, Romania. RESULTS: During the 10-year period, 7 patients were diagnosed with Nicolau syndrome. Of these, 4 (57%) patients were males and 3 (43%) were females, The male to female ratio was 1.33. The median age was 64 (interquartile range, IQR, 62–71), with the youngest patient being diagnosed at age 61 and the oldest at age 74. Regarding the drugs classes that caused Nicolau syndrome, these were intravenous antibiotics in 57%, and non-steroidal anti-inflammatory drugs in 43% of cases. CONCLUSION: All patients healed in a period of 6 to 8 weeks. No complications occurred. In conclusion, Nicolau syndrome is a rare side effect of injectable drug administration.
format Online
Article
Text
id pubmed-10653301
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106533012023-11-02 Embolia cutis Medicamentosa (Nicolau syndrome): case series Fekete, Gyula Laszlo Iantovics, Laszlo Barna Fekete, Júlia Edit Fekete, Laszlo Front Med (Lausanne) Medicine INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was to describe and analyze the clinical characteristics of Nicolau syndrome in patients examined in daily dermatological practice. METHODS: We performed a retrospective chart review, between January 2011 and December 2020, in patients diagnosed with Nicolau syndrome, from the cases of a private dermatology medical office in Târgu Mureș, Romania. RESULTS: During the 10-year period, 7 patients were diagnosed with Nicolau syndrome. Of these, 4 (57%) patients were males and 3 (43%) were females, The male to female ratio was 1.33. The median age was 64 (interquartile range, IQR, 62–71), with the youngest patient being diagnosed at age 61 and the oldest at age 74. Regarding the drugs classes that caused Nicolau syndrome, these were intravenous antibiotics in 57%, and non-steroidal anti-inflammatory drugs in 43% of cases. CONCLUSION: All patients healed in a period of 6 to 8 weeks. No complications occurred. In conclusion, Nicolau syndrome is a rare side effect of injectable drug administration. Frontiers Media S.A. 2023-11-02 /pmc/articles/PMC10653301/ /pubmed/38020151 http://dx.doi.org/10.3389/fmed.2023.1216781 Text en Copyright © 2023 Fekete, Iantovics, Fekete and Fekete. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Fekete, Gyula Laszlo
Iantovics, Laszlo Barna
Fekete, Júlia Edit
Fekete, Laszlo
Embolia cutis Medicamentosa (Nicolau syndrome): case series
title Embolia cutis Medicamentosa (Nicolau syndrome): case series
title_full Embolia cutis Medicamentosa (Nicolau syndrome): case series
title_fullStr Embolia cutis Medicamentosa (Nicolau syndrome): case series
title_full_unstemmed Embolia cutis Medicamentosa (Nicolau syndrome): case series
title_short Embolia cutis Medicamentosa (Nicolau syndrome): case series
title_sort embolia cutis medicamentosa (nicolau syndrome): case series
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653301/
https://www.ncbi.nlm.nih.gov/pubmed/38020151
http://dx.doi.org/10.3389/fmed.2023.1216781
work_keys_str_mv AT feketegyulalaszlo emboliacutismedicamentosanicolausyndromecaseseries
AT iantovicslaszlobarna emboliacutismedicamentosanicolausyndromecaseseries
AT feketejuliaedit emboliacutismedicamentosanicolausyndromecaseseries
AT feketelaszlo emboliacutismedicamentosanicolausyndromecaseseries